The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Proof of principle for transfusion of in vitro–generated red blood cells
Open accessAbstract
In vitro RBC production from stem cells could represent an alternative to classic transfusion products. Until now the clinical feasibility of this concept has not been demonstrated. We addressed the question of the capacity of cultured RBCs (cRBCs) to survive in humans. By using a culture protocol permitting erythroid differentiation from peripheral CD34+ HSC, we generated a homogeneous population of cRBC functional in terms of their deformability, enzyme content, capacity of their hemoglobin to fix/release oxygen, and expression of blood group antigens. We then demonstrated in the nonobese diabetes/severe combined immunodeficiency mouse that cRBC encountered in vivo the conditions necessary for their complete maturation. These data provided the rationale for injecting into one human a homogeneous sample of 1010 cRBCs generated under good manufacturing practice conditions and labeled with 51Cr. The level of these cells in the circulation 26 days after injection was between 41% and 63%, which compares favorably with the reported half-life of 28 ± 2 days for native RBCs. Their survival in vivo testifies globally to their quality and functionality. These data establish the proof of principle for transfusion of in vitro–generated RBCs and path the way toward new developments in transfusion medicine. This study is registered at http://www.clinicaltrials.gov as NCT0929266.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Johnstone, R. M., Adam, M., Hammond, J. R., Orr, L., & Turbide, C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48095-7 · Cited by 2,931
Determination of lymphocyte division by flow cytometry
Lyons, A. B., & Parish, C. R. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90236-4 · Cited by 1,657
Induction of pluripotent stem cells from fibroblast cultures
Takahashi, K., Okita, K., Nakagawa, M., & Yamanaka, S. (2007) · Nature Protocols · doi:10.1038/nprot.2007.418 · Cited by 1,086
Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells
Giarratana, M.-C., Kobari, L., Lapillonne, H., Chalmers, D., Kiger, L., Cynober, T., Marden, M. C., Wajcman, H., & Douay, L. (2005) · Nature Biotechnology · doi:10.1038/nbt1047 · Cited by 574
Self-citationEbaugh, F. G., Emerson, C. P., Ross, J. F., Aloia, R., Halperin, P., & Richards, H. (1953) · Journal of Clinical Investigation · doi:10.1172/jci102855 · Cited by 344
Biologic properties and enucleation of red blood cells from human embryonic stem cells
Lu, S.-J., Feng, Q., Park, J. S., Vida, L., Lee, B.-S., Strausbauch, M., Wettstein, P. J., Honig, G. R., & Lanza, R. (2008) · Blood · doi:10.1182/blood-2008-05-157198 · Cited by 293
Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo
Neildez-Nguyen, T. M. A., Wajcman, H., Marden, M. C., Bensidhoum, M., Moncollin, V., Giarratana, M.-C., Kobari, L., Thierry, D., & Douay, L. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-467 · Cited by 267
Self-citationvon Lindern, M., Zauner, W., Mellitzer, G., Steinlein, P., Fritsch, G., Huber, K., Löwenberg, B., & Beug, H. (1999) · Blood · doi:10.1182/blood.v94.2.550 · Cited by 248
Lapillonne, H., Kobari, L., Mazurier, C., Tropel, P., Giarratana, M.-C., Zanella-Cleon, I., Kiger, L., Wattenhofer-Donze, M., Puccio, H., Hebert, N., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.023556 · Cited by 242
Self-citation
Cited by
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Canver, M. C., Smith, E. C., Sher, F., Pinello, L., Sanjana, N. E., Shalem, O., Chen, D. D., Schupp, P. G., Vinjamur, D. S., Garcia, S. P., et al. (2015) · Nature · doi:10.1038/nature15521 · Cited by 886
Kurita, R., Suda, N., Sudo, K., Miharada, K., Hiroyama, T., Miyoshi, H., Tani, K., & Nakamura, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059890 · Cited by 418
Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells
Hoban, M. D., Cost, G. J., Mendel, M. C., Romero, Z., Kaufman, M. L., Joglekar, A. V., Ho, M., Lumaquin, D., Gray, D., Lill, G. R., et al. (2015) · Blood · doi:10.1182/blood-2014-12-615948 · Cited by 320
Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders
Bauer, D. E., Kamran, S. C., & Orkin, S. H. (2012) · Blood · doi:10.1182/blood-2012-06-292078 · Cited by 177
Bauer, D. E., & Orkin, S. H. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.08.001 · Cited by 143
Metadata
- Authors
- Giarratana, M.-C., Rouard, H., Dumont, A., Kiger, L., Safeukui, I., Le Pennec, P.-Y., François, S., Trugnan, G., Peyrard, T., Marie, T., Jolly, S., Hebert, N., Mazurier, C., Mario, N., Harmand, L., Lapillonne, H., Devaux, J.-Y., & Douay, L.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2011-11-10
- Volume
- 118
- Issue
- 19
- Pages
- 5071-5079
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1967521279
- Cited by
- 342
- References
- 35
- FWCI
- 16.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proof of principle for transfusion of in vitro–generated red blood cells. https://app.cochat.ai/papers/10.1182/blood-2011-06-362038
- The paper
- Giarratana, M.-C., Rouard, H., Dumont, A., Kiger, L., Safeukui, I., Le Pennec, P.-Y., François, S., Trugnan, G., Peyrard, T., Marie, T., Jolly, S., Hebert, N., Mazurier, C., Mario, N., Harmand, L., Lapillonne, H., Devaux, J.-Y., & Douay, L. (2011). Proof of principle for transfusion of in vitro–generated red blood cells. Blood. https://doi.org/10.1182/blood-2011-06-362038
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
